Stay updated on Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, and the funding-status notice along with the previous Revision: v3.4.1 note has been removed; this is a site-wide messaging update that does not alter the study content.
    Difference
    0.4%
    Check dated 2026-02-11T10:31:16.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a global notice about a lapse in government funding with status update that the NIH Clinical Center is open, and updated the site version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:20:34.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added a Show glossary feature and updated study record metadata to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. The previous labels used 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:09:55.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Updated the page revision from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:21:10.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    A unified 'Locations' section was added listing Illinois, Indiana, Massachusetts, New Jersey, and New York, replacing the previous separate 'XYZ Locations' headers. The page revision updated to v3.3.3 and the 'HHS Vulnerability Disclosure' link was removed.
    Difference
    0.6%
    Check dated 2025-12-23T17:19:00.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    Publication notes were adjusted to specify that PubMed-listed publications are auto-generated and may not be related to the study. The revision tag changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:48:23.000Z thumbnail image

Stay in the know with updates to Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.